Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pan-Retinal Photocoagulation With Intravitreal Ranibizumab In Treatment Of Proliferative Diabetic Retinopathy

NCT07819253 is registered in ClinicalTrials.gov with Aswan University as lead sponsor.

NCT NCT07819253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07819253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pan-Retinal Photocoagulation With Intravitreal Ranibizumab In Treatment Of Proliferative Diabetic Retinopathy
Lead sponsor
Aswan University
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2023
Completion date
July 31, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy (pdr)